Purpose:This is a two-arm preliminary efficacy RCT in 120 participants testing a 6-week home-based walking and progressive resistance exercise program (EXCAP©®) vs. standard care on CIPN, interoception, and inflammation. Participants: This study will enroll 120 participants receiving neurotoxic chemotherapy or have completed neurotoxic chemotherapy in the past nine months (i.e., taxane-, platinum-, vinca alkaloid-, epothilone-, or proteasome inhibitor-based chemotherapy). Procedures (methods): Participants will complete questionnaires, clinical assessments, and a blood draw at two time points: pre-intervention (week 0, T1) and post-intervention (approximately week 6, T2).

This is a study to assess patient, provider, and pharmacist perceptions of delivering FIT kits for colorectal cancer screening in pharmacy settings.

The goal of this study is to assess the feasibility of a nutrition program for individuals with cancer who are undergoing treatment. The nutrition program includes counseling from a registered dietitian, food logging, and nutrition symptom tracking.

Develop a device to measure patient preferences in the treatment of bladder cancer.

The purpose of this study is to validate a new voice-enabled tablet to ensure it is an accurate and acceptable way to administer PROs questionnaires in Malawi. This voice-enabled tablet was developed specifically for patient populations who are unable to comfortably read and write, so that they can have equal access to participating in direct self-reporting their own PROs Questionaries without needing and interviewer to assist them. Once validated in the first 50 participants, then we will continue to enroll 500 participants who will take the PROMIS-25 and/or PRO-CTCAE Questionnaires at various time points throughout their treatment. This will allow you to directly self-complete the PRO surveys and give you a voice so that your struggles, quality of life, and symptoms can be more accurately and comprehensively communicated to the medical care team. We hope that through administering these PROs questionnaires, it will also improve the overall care, management of

The Improving Provider Announcement Communication Training (IMPACT) national primary care team survey aims to investigate HPV vaccine communication among a large sample of primary care team members, including physicians, physician assistants, nurse practitioners, registered nurses and medical assistants to inform future provider communication interventions.

The purpose of this study is to further adapt an evidence-based, social support intervention, enCompass for rural cancer caregivers by identifying the barriers and facilitators from the perspectives of clinical staff and healthcare administrators. Results of this study will inform the development of a clinical trial.

Aim 1: To co-develop the "Patient-Centered Pharmacy Pathway for Oral Chemotherapy" (P3OC) components through stakeholder engagement by conducting a modified Delphi panel with pharmacists, physicians, and other oncology healthcare providers (36,37) to determine key symptoms to assess during oral chemotherapy. Aim 2: To conduct usability testing(38,39) of the P3OC EHR Smart Form, verbal PROM, and report/dashboard with pharmacists.

The purpose of this research study is to understand how the monitoring of Patient-Reported Outcomes (PROs) could help improve surgical care for patients undergoing chest surgeries. PROs are symptoms directly reported by patients through the completion of a survey.

In Aim 1, we will use existing research and expert review to develop new text and pictorial LCC warnings and test the new warnings using online experiments to identify warnings that adult LCC users perceive as most effective. The proposed study will fill critical gaps regarding which characteristics make LCC warning labels most effective and provide needed evidence on how LCC warnings influence LCC behavioral intentions. Our overarching goal is to develop effective LCC warnings that reduce cancer and other health risks.